Management of thrombosed dialysis access circuits

G Maleux - CardioVascular and Interventional Radiology, 2023 - Springer
Thrombotic occlusion of autologous arteriovenous fistulas or synthetic arteriovenous grafts is
a serious adverse event in hemodialysis patients and declotting should be performed before …

Comparison of pharmacological thrombolysis with mechanical thrombectomy in thrombosed arteriovenous fistulas and grafts: a systemic review and meta-analysis

TKC Tay, G Rehena, KD Zhuang, FG Irani, A Gogna… - Clinical Radiology, 2024 - Elsevier
AIM To compare the effectiveness and safety of pharmacological thrombolysis and
mechanical thrombectomy. MATERIAL AND METHODS This review was conducted in …

[HTML][HTML] Endovascular salvage of thrombosed haemodialysis vascular access

G Deogaonkar, N Thulasidasan, R Phulambrikar… - Vasa, 2022 - econtent.hogrefe.com
Background: Haemodialysis access thrombosis is associated with significant morbidity and
access abandonment rates, for which endovascular salvage is a well described treatment …

Single-center prospective pilot study of sirolimus drug-coated balloon angioplasty in maintaining the patency of thrombosed arteriovenous graft

CW Tan, RY Tan, SC Pang, ARK Tng, TY Tang… - Journal of Vascular and …, 2021 - Elsevier
Purpose To investigate the use of a sirolimus drug-coated balloon (DCB) in the
management of a thrombosed arteriovenous graft (AVG). Materials and Methods A single …

Comparing patency rates of arteriovenous dialysis access following percutaneous thrombectomy using various catheter directed therapies

A Hicks, A Grzeda, J Schucht, J Bond, C Bush… - Annals of Vascular …, 2023 - Elsevier
Background Arteriovenous fistulas often require frequent interventions to maintain patency
for hemodialysis. Interventions may include open or percutaneous thrombectomy with …

Efficacy and safety of low dose, weight-based subcutaneous enoxaparin protocol in recurrent arteriovenous access thrombosis

CC Gan, RY Tan, MA Cheong… - The Journal of …, 2024 - journals.sagepub.com
Background: This study aims to evaluate the safety and efficacy of a short-term, low dose,
weight-based subcutaneous enoxaparin protocol (SEP) in maintaining the patency of …

The Cleaner XT™ device as an endovascular adjunct for pharmacomechanical thrombolysis of thrombosed arteriovenous fistulas and grafts

KWSJ Huan, CS Tan, D Chua, CJQ Yap… - Annals of Vascular …, 2020 - jstage.jst.go.jp
Objective: This paper documents our experience using the Cleaner XT™ device (Argon
Medical Devices, Plano, TX, USA) for pharmacomechanical thrombolysis (PMT) of …

The Delay of Recanalisation of Acutely Thrombosed Dialysis Arteriovenous Access Until the Next Workday has No Negative Impact on Clinical Outcome

K Hellwig, S Zicha, C Kopp, U Rother… - CardioVascular and …, 2024 - Springer
Purpose The necessity of providing endovascular recanalization of acutely thrombosed
arteriovenous access (AV access) during weekend is questionable, since hemodialysis can …

[HTML][HTML] Perioperative and long-term outcomes after percutaneous thrombectomy of arteriovenous dialysis access grafts

N Arinze, T Ryan, R Pillai, R Vilvendhan… - Journal of Vascular …, 2020 - Elsevier
Objective Maintenance of functional arteriovenous grafts (AVGs) for dialysis is difficult
secondary to low primary patency, need for reinterventions, and limited alternative dialysis …

Clinical outcomes following the surgery of new autologous arteriovenous fistulas proximal to the failed ones in end-stage renal disease patients: a retrospective cohort …

X Kong, L Tang, L Liang, W Cao, L Zhang, W Yong… - Renal …, 2019 - Taylor & Francis
Background: Most prior studies have explored surgery for the treatment of failed autologous
arteriovenous fistulas (AVFs) with limited follow-up times and a lack of end point mortality …